Previous 10 | Next 10 |
Onconova Therapeutics ([[ONTX]] -4.8%) announces the appointment of Mark Gelder as the company's chief medical officer ((CMO)), effective as of June 14, 2021.Gelder has more than 35 years of experience in clinical development, medical affairs, and medical marketing.He was most ...
U.S. equity markets rallied this past week as long-term inflation expectations eased following a lukewarm slate of economic data and as massive new government spending programs face diminishing public support. Snapping a two-week skid, the S&P 500 rallied 1.2% on the week. Bitcoin...
Market leadership by sector and market cap. Sectors remain tilted toward mid-cycle ideas. However, stock-specific ideas are available in every basket. For further details see: The Top Stocks You Can Buy Now
ORC and ARR each have a dividend yield of 10% or higher, but that doesn’t mean prices are attractive. Investors focusing only on the dividend yield can miss the forest for the trees. The historical price-to-book ratios demonstrate that the REITs usually trade within a range...
Part 1 of this article compares NLY’s recent investment composition, leverage, hedging coverage ratio, quarterly BV, economic return, and current valuation to nineteen mREIT peers. Providing sector-wide metrics allow readers to better understand which mREIT companies will likel...
REITs recorded a sequential improvement across all critical metrics in Q1, powering a historic wave of dividend growth in early 2021. However, several harder-hit property sectors are far from fully-recovered. The Great Financial Crisis resulted in long-term, lasting pain for the real ...
Comparing future cash flows from individual preferred shares can be a useful tool for figuring out which share should be worth more. IVR-B and IVR-C are out of whack. Neither is great, but IVR-C is clearly a better deal when it costs $.50 less than IVR-B. There’s a better d...
ORC offers an attractive price-to-book valuation of 1.13. A high forward-looking dividend yield of 13.95% makes ORC an interesting investment for dividend seekers. With a high net profit margin of 84.32%, ORC compares well to its competitors. For further details see: Orc...
We take a look at the Capstead Mortgage Corp. preferred CMO.PE post Q1 earnings numbers. CMO has a relatively high yield profile in the agency-focused sector at 7.49% yield with a high agency allocation focus. However, the relatively low coverage, no call protection, elevated leve...
One of our strong buy ratings from 2020 needs an update. GPMT destroyed the bears. GPMT was priced for disaster. It never happened. Unless someone was shorting GPMT. That person would have a disaster. Spreads between assets and hedges in agency and non-agency mREITs (ignores comme...
News, Short Squeeze, Breakout and More Instantly...
Capstead Mortgage Corporation Company Name:
CMO Stock Symbol:
NYSE Market:
Capstead Mortgage Corporation Website:
Franklin BSP Realty Trust, Inc. (f/k/a Benefit Street Partners Realty Trust, Inc.) (“FBRT” or the “Company”) and Capstead Mortgage Corporation (NYSE: CMO) (“Capstead”) today announced the completion of their previously announced merger pursuant ...
Capstead Mortgage Corporation (NYSE: CMO) (“Capstead”) announced that at its special meeting of stockholders held today, conducted by means of a virtual meeting held live over the internet, Capstead stockholders approved the merger transaction (the “Merger”) ...
Franklin BSP Realty Trust, Inc. (f/k/a Benefit Street Partners Realty Trust, Inc.) (“FBRT”), a publicly-registered, non-listed real estate investment trust (“REIT”), and Capstead Mortgage Corporation (NYSE: CMO) (“Capstead”), a REIT, today annou...